WEBULL
WebtradeDownload

Anterix (ATEX) Could Be 6% Undervalued Following Its Spectrum Monetization Debate

Simply Wall St · 3d ago

Anterix (ATEX) drew fresh attention after its recent share move, with the price closing at $81.18. Investors are weighing this telecom-focused spectrum holder in light of its mixed return profile and modest annual revenue base.

The short term picture around Anterix has been choppy, with the share price falling 2.67% in the last session and down 24.03% over 90 days. However, the year-to-date share price return of 265.18% and 1-year total shareholder return of 268.50% still point to momentum that has sharply shifted investor expectations on this relatively small revenue base.

Scan how Anterix fits alongside other telecom and infrastructure plays by reviewing our curated list of 43 power grid technology and infrastructure stocks before the next round of headlines reshapes expectations.

Anterix now trades well below the average analyst target, yet sits on a small revenue base and volatile returns. Is this a discount on misunderstood spectrum optionality, or a warning that the market is right to price in caution?

Most Popular Narrative: 6% Undervalued

At $81.18, Anterix trades below the most followed fair value estimate of $86.00, a small gap that still hinges on how 900 MHz spectrum turns into long term cash generation under a 7.24% discount rate.

Although utilities are showing interest in private broadband networks as they modernize grids, Anterix still has roughly 85% of its spectrum yet to be monetized. Any delay in converting that interest into contracts could slow the realization of expected spectrum value and defer cash inflows and earnings.

See why 0 investors see Anterix as 6% undervalued.

Result: Fair Value of $86.00 (UNDERVALUED)

Still, the Anterix story can change quickly if utilities slow contract signings, or if spectrum clearing and FCC licensing take longer than investors expect.

Find out about the key risks to this Anterix narrative.

Another View On Anterix’s Valuation

The first fair value story around Anterix leans on analyst targets and spectrum potential. A very different picture comes from our DCF model, which puts future cash flow value at $51.51 per share, well below the current $81.18 price and pointing to an overvalued signal. Which lens do you trust more for a long term thesis?

For a closer look at how this gap is built up over time, review the SWS DCF model output in detail, then test whether its cash flow path lines up with your own expectations for spectrum deals and utility contracts. Look into how the SWS DCF model arrives at its fair value.

ATEX Discounted Cash Flow as at Oct 2026
ATEX Discounted Cash Flow as at Oct 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Anterix for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 29 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed messages on Anterix can either sharpen your thinking or leave you stuck on the sidelines, so move quickly, test the numbers, and weigh both sides using the 1 key reward and 3 important warning signs.

Looking for more investment ideas beyond Anterix?

If Anterix has sharpened your thinking, do not stop here. Broaden your watchlist with fresh opportunities that match your risk, return, and income goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.